Lay opinion vs evidence: FTO Senioren

Lay opinion often frames FTO (fat mass and obesity-associated gene) as a 'fat gene' that predestines seniors to obesity regardless of lifestyle. Evidence tells a more nuanced story. FTO variants (e.g., rs9939609) are among the most robust GWAS hits for BMI, but each risk allele increases BMI by only ~0.3–0.4 kg/m². In seniors, the effect is even smaller because age-related metabolic decline, sarcopenia, and hormonal shifts play larger roles. Large meta-analyses confirm the association but emphasize that lifestyle modification (diet, exercise) can substantially attenuate the genetic risk. Consumer DNA tests often overstate the impact, leading to fatalism. The reality: FTO is a small piece of a complex puzzle. For seniors, focusing on protein intake, resistance training, and overall energy balance is far more impactful than worrying about a single gene. No clinical guidelines recommend FTO testing for weight management. Evidence level: human-moderate (GWAS confirmed, effect small).